- Report
- May 2026
- 201 Pages
Global
From €4169EUR$4,650USD£3,562GBP
- Report
- June 2026
- 414 Pages
Global
From €4438EUR$4,950USD£3,792GBP
- Report
- July 2025
- 231 Pages
Global
From €2242EUR$2,500USD£1,915GBP
- Report
- August 2025
- 182 Pages
Global
From €4035EUR$4,500USD£3,447GBP
- Report
- January 2022
- 114 Pages
Global
From €4259EUR$4,750USD£3,639GBP
- Report
- July 2024
- 157 Pages
Global
From €3049EUR$3,400USD£2,605GBP
€3811EUR$4,250USD£3,256GBP
- Report
- May 2025
- 188 Pages
Global
From €3239EUR$3,613USD£2,768GBP
€3811EUR$4,250USD£3,256GBP
- Report
- February 2024
- 95 Pages
Global
From €3500EUR$4,182USD£3,095GBP
In Vitro Toxicity Testing is a type of In Vitro Diagnostics (IVD) that assesses the potential toxicity of a substance or product. It is used to evaluate the safety of a drug, chemical, or other material before it is used in humans or animals. Toxicity testing is conducted in a laboratory setting using cell cultures, tissues, or other biological systems. The results of these tests can help determine the safety of a product or substance and can be used to inform regulatory decisions.
In Vitro Toxicity Testing is a growing market, with a range of companies offering services and products. Examples include Promega Corporation, Bio-Rad Laboratories, Thermo Fisher Scientific, Merck KGaA, and Agilent Technologies. Show Less Read more